Acumen Pharmaceuticals(us:ABOS)
1.08
-1.82%
Updated on 2025-04-02
Open:1.10
Close:1.08
High:1.13
Low:1.06
Prev Close:1.10
Volume:234738.00
Turnover:255366.36
Turnover Ratio:0.39%
Shares:60.57M
MarketCap:65.12M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 102 | 43558730 | 72.50% | 22 | 22 | 41 |
| 2024-03-31 | 90 | 43365234 | 72.18% | 24 | 22 | 35 |
| 2023-12-31 | 84 | 38440166 | 66.38% | 20 | 28 | 27 |
| 2023-09-30 | 75 | 43185884 | 74.57% | 25 | 23 | 21 |
| 2023-06-30 | 69 | 24655300 | 60.10% | 8 | 14 | 38 |
| 2023-03-31 | 66 | 26076450 | 63.56% | 8 | 18 | 29 |
| 2022-12-31 | 69 | 27102674 | 66.06% | 19 | 19 | 25 |
| 2022-09-30 | 62 | 27507913 | 67.92% | 15 | 17 | 23 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Ra Capital Management, L.P. | 14932063 | 24.85% | 0 | |
| 2024-03-31 | Sands Capital Ventures, Llc | 3417075 | 5.69% | 0 | |
| 2024-03-31 | Franklin Resources Inc | 3395418 | 5.65% | 36609 | 1.09% |
| 2024-03-31 | Millennium Management Llc | 2629541 | 4.38% | 1134257 | 75.86% |
| 2024-03-31 | Rock Springs Capital Management Lp | 2300059 | 3.83% | 0 | |
| 2024-03-31 | Fmr Llc | 2089000 | 3.48% | 2089000 | |
| 2024-03-31 | Laurion Capital Management Lp | 1895023 | 3.15% | 0 | |
| 2024-03-31 | Vanguard Group Inc | 1665058 | 2.77% | -174494 | -9.49% |
| 2024-03-31 | Knollwood Investment Advisory, Llc | 1628510 | 2.71% | 0 | |
| 2024-03-31 | Price T Rowe Associates Inc /Md/ | 1098276 | 1.83% | 1098276 |
About
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.
Address:427 Park Street
Website:http://www.acumenpharm.com
Market Movers